摘要
本文简要介绍了当今基因治疗ＨＩＶ感染的基本策略，包括诱导性杀伤受染细胞，加强机体免疫力，干扰ＨＩＶ复制等。
出处
《免疫学杂志》
CAS
CSCD
北大核心
1994年第4期211-213,共3页
Immunological Journal
同被引文献34
-
1邹全明,李华,鲁东水,李文健.抗HIV病毒药物结构设计的进展[J].免疫学杂志,1997,13(1):55-57. 被引量：2
-
2[1]Woo PC, Wong LP, Zheng B J, et al. Unique immunogenicity of Hepattis B virus DNA vaccine presented by live-attenuated Salmonella typhimurium [J]. Vaccine, 2001,19(20/22) :2 945 - 2 954.
-
3[2]Zheng B, Woo PC, Ng M, et al. A crucial role of macrophages in the immune responses to oral DNA vaccination Hepatitis B virus in a murine model[J]. Vaccine, 2001,20( 1/2): 140 - 147.
-
4[3]Hopkins S, Kraehenbuhl JP, Schodel F, et al. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization [ J ]. Infect Immun,1995,63(9) :3 279 - 3 286.
-
5[4]Haefliger DN, Benyacoub J, Lemoine R, et al. Nasal vaccination with attenuated Salmonella typhimurium strains expressing the hepatitis B nucleocapsid: dose response analysis[J].Vaccine, 2001,19(20/22) :2 854 - 2 861.
-
6[5]Schodel F, Milich DR, Will H. Hepatitis B virus nucleocapsid/per-S2 fusion proteins expressed in attenuated salmonella for oral vaccination[J]. J Immunol, 1990,145(12) :4 317 -4 321.
-
7[6]Schodel F, Kelly SM, Peterson DL, et al. Hybrid Hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination[J].Infect Immun, 1994,62(5):1 669-1 676.
-
8[7]Schodel F, Kelly SM, Tinge S, et al. Hybrid Hepatits B virus core antigen as a vaccine carrier moiety Ⅱ expression in avirulent salmonella spp for mucosal immunization [ J ]. Adv Exp Med Biol, 1996,397(1):15- 21.
-
9[8]Wedemeyer H, GagnetenS, DavisA, etal. Oralimmunization with HCV-NS3-transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model[J]. Gastroenterol,2001,121(5): 1 158 - 1 166.
-
10[12]Fouts TR, Tuskan RG, Chada S, et al. Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120[J]. Vaccine, 1995, 13(17): 1 697 -1 705.
-
1周乐,黄瑶,张秀玲,张伟.扬州市2011年-2013年手足口病病原学监测分析[J].中国卫生检验杂志,2014,24(24):3592-3593. 被引量：3
-
2康宁,闭福银,谭毅,周开姣.2009年广西253例疑似肠道病毒感染病例病原学监测结果分析[J].中华疾病控制杂志,2010,14(12):1210-1212. 被引量：4
-
3金荣华.RNA干扰可在变异前阻断HIV复制[J].传染病网络动态,2002(8):29-30.
-
4高健.患有血友病的艾滋病患者可采用高效抗逆转录病毒治疗[J].中华医学信息导报,2009,24(8):12-12.
-
5张春迎,陈军,郑煜煌,雷建华,周华英,张永红,何艳,罗开忠,蒋永芳,欧秋英,黄竹林.艾滋病患者高效抗逆转录病毒治疗两年的效果和副作用[J].中华内科杂志,2006,45(6):494-496. 被引量：33
-
6曹菊.他汀类药可能抑制HIV复制[J].国外药讯,2004(12):21-21.
-
7张宁.减轻结核病在公共机构传染的影响控制感染策略以外的措施[J].冶金防痨,1999,8(3):174-175.
-
8闭志友,刘伟,梁淑家,陈杰,梁富雄,李剑军,周崇兴,黎峰,黄达春,罗觅.有效抑制HIV复制下AIDS儿童患者外周血T淋巴细胞亚群的变化分析[J].现代预防医学,2013,40(8):1512-1513.
-
9吴江南,周勇,黄丽芳,何爱华,郑金凤,张山鹰,严延生.乙型肝炎疫苗免疫时间和接种状况对预防HBV感染的影响[J].中华流行病学杂志,2014,35(4):471-472. 被引量：7
-
10肖向梅.28例HIV/AIDS住院病人的免疫功能临床研究[J].中外医疗,2010,29(26):36-36.
